Status:
ACTIVE_NOT_RECRUITING
Outcomes of Patients Who Survived Treatment on an Intensive Care Unit for COVID-19 in England and Wales
Lead Sponsor:
University of Oxford
Collaborating Sponsors:
Intensive Care National Audit & Research Centre
Conditions:
Covid19
Myocardial Infarction
Eligibility:
All Genders
16+ years
Brief Summary
This retrospective cohort study aims to characterise outcomes for patients treated on an intensive care unit (ICU) with COVID-19 in England and Wales, one year after discharge from hospital. Outcomes ...
Detailed Description
Across England and Wales, over 10,000 patients have been treated for severe coronavirus disease 2019 (COVID-19) on an intensive care unit. Around 60% survived to leave hospital. It is unknown how surv...
Eligibility Criteria
Inclusion
- Age 16 years or over
- Admitted to an adult, general ICU in England or Wales as an emergency (unplanned)
- Admitted to ICU for either: a) confirmed COVID-19 between 1st January to 1st July 2020 or b) without confirmed COVID-19 between 1st July 2016 and 1st July 2020-
Exclusion
- Patients who died in hospital after treatment on an ICU
Key Trial Info
Start Date :
August 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 28 2025
Estimated Enrollment :
319600 Patients enrolled
Trial Details
Trial ID
NCT04838106
Start Date
August 1 2020
End Date
February 28 2025
Last Update
August 14 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Critical Care Research Group, Nuffield Department of Clinical Neurosciences, University of Oxford
Oxford, Oxfordshire, United Kingdom, OX3 9DU